ALB and fibrosis: Based on clinical laboratory analyses (Table S5), which showed 20% lower plasma albumin concentrations for patients with stage F4 liver fibrosis than those with no fibrosis, a 20% decrease in the fraction of blood chlordecone binding to plasma albumin was applied.